← Leaderboards
Debra A Schaumberg
Brigham And Women'S Hospital
$6,275,999
Attributed
$7,422,245
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–15$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,422,245 · 5
By mechanism
R01$7,319,366 · 4
K23$102,879 · 1
Top collaborators
- William G Christen3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Julie E Buring$63,823,301
- Joann Elisabeth Manson$50,755,529
- Meryl S Leboff$9,246,227
- Christine M Albert$20,759,435
- William G Christen$8,237,211
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanPublic Health Medicine (Field)PreventiveIncidenceResourcesRisk FactorsQuestionnairesBiologicalProspective StudiesCohortProgramsBlindnessParticipantVascular Endothelial Growth FactorsBaseDesignAge Related Macular DegenerationCohort StudiesComplement Factor HElderlyCase ControlGenesCostEpidemiology
Grant awards (16)
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED$58,721
R01 · FY2015 · EY · contact PI
VITAL-AMD: Prevention of AMD in the VITamin D and OmegA-3 Trial$776,751
R01 · FY2014 · EY
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED$373,156
R01 · FY2014 · EY · contact PI
VITAL-AMD: Prevention of AMD in the VITamin D and OmegA-3 Trial$734,082
R01 · FY2013 · EY
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED$361,328
R01 · FY2013 · EY · contact PI
VITAL-AMD: Prevention of AMD in the VITamin D and OmegA-3 Trial$781,659
R01 · FY2012 · EY
Omega-3 Fatty Acids for Prevention of Dry Eye Disease: VITAL-DED$401,625
R01 · FY2012 · EY · contact PI
Genetic Epidemiology of Age-Related Macular Degeneration$575,010
R01 · FY2011 · EY · contact PI
Genetic Epidemiology of Age-Related Macular Degeneration$601,411
R01 · FY2010 · EY · contact PI
Genetic Epidemiology of Age-Related Macular Degeneration$587,209
R01 · FY2009 · EY · contact PI
Genetic Epidemiology of Age-Related Macular Degeneration$570,015
R01 · FY2008 · EY · contact PI
Genetic Epidemiology of Age-Related Macular Degeneration$553,392
R01 · FY2007 · EY · contact PI
Molecular Risk Factors for Age-Related Maculopathy$315,000
R01 · FY2004 · EY
Molecular Risk Factors for Age-Related Maculopathy$315,000
R01 · FY2003 · EY
Molecular Risk Factors for Age-Related Maculopathy$315,007
R01 · FY2002 · EY
RISK FACTORS FOR AGE-RELATED EYE DISEASES$102,879
K23 · FY2000 · EY